MISSISSAUGA, ON, March 7,
2023 /CNW/ - Cymat Technologies Ltd. (TSXV: CYM)
(OTCQB: CYMHF) (the "Company" or "Cymat") is
pleased to announce that it intends to reprice outstanding warrants
and initiate a warrant exercise incentive program.
The Company intends to reprice an aggregate of 3,859,862
outstanding common share purchase warrants ("Warrants")
issued pursuant to its May 5, 2021
private placement. The Warrants have an exercise price of
$0.90 and an expiry date of
May 5, 2023. Management believes
repricing these "out of the money" Warrants could encourage their
earlier exercise, improving the Company's balance sheet and helping
to finance a number of business development opportunities in the
automotive and military sectors. The Warrants will be deemed to be
amended to adjust their exercise price to $0.45 per share (the "Amended Warrants").
The Amended Warrants will also be deemed to have been amended to
include an acceleration provision whereby, if for any ten (10)
consecutive trading days (the "Premium Trading Days")
following the repricing the closing price of the Company's
common shares ("Common Shares") exceeds $0.5625, the Amended Warrants' expiry date will
be accelerated such that holders will have thirty (30)
calendar days to exercise the Amended Warrants (if they have not
first expired in the normal course)(the "Acceleration
Clause"). The activation of the Acceleration Clause will be
announced by press release and the 30-day period will commence
seven (7) days after the last Premium Trading Day.
The amendment of the Warrants is subject to the prior consent of
all Warrant holders and the approval and the approval of TSX
Venture Exchange (the "Exchange") ("Warrant Amendment
Approval").
The Company also announces that if it obtains Warrant Amendment
Approval, it will institute a warrant exercise incentive program
(the "Incentive Program") designed to encourage the early
exercise of the 3,859,862 Amended Warrants. Under the Incentive
Program, the Company will offer an inducement to each Warrant
holder that exercises its Amended Warrants prior to 4:00 pm Toronto
time on March 31, 2023, by the
issuance of one additional Common Share purchase warrant (an
"Incentive Warrant") for each Warrant exercised. Each
Incentive Warrant will entitle the holder to purchase one
additional Common Share of the Company at a price of $0.60 for a period of two (2) years from the date
of the Warrant Amendment Approval and will be subject to a four
month and one day hold period from their date of issuance.
The Incentive Program will commence upon receipt of Warrant
Amendment Approval and will expire on March
31, 2023 at 4:00 p.m.
(Toronto time).
Michael Liik, CEO and Chairman of
Cymat commented "The company is currently involved in several
automotive and military development programs which require ongoing
funding." He added, "The proceeds from the exercise of these
warrants will also buttress our balance sheet and demonstrate
staying power to our commercial partners at this critical
juncture."
The Company intends to issue an updating news release upon
receipt, if any, of Warrant Amendment Approval and commencement of
the Incentive Program, outlining the terms and conditions and the
method of exercising Warrants pursuant to the Incentive Program.
The Incentive Program is subject to approval by the Exchange.
About Cymat Technologies
Ltd.
Cymat Technologies Ltd. has the global rights, through patents
and established know-how, to manufacture and sell Stabilized
Aluminum Foam ("SAF"), a unique, ultra-light, cellular metallic
material. The proprietary production process entails the injection
of gases through a molten bath of alloyed aluminum infused with
ceramic particles. The result is an advanced, lightweight,
recyclable material that exhibits unique characteristics including
customizable density and dimensions; mechanical energy absorption;
thermal and acoustic insulation; and time, temperature, and
strain-rate insensitivity. A key benefit of this continuous foam
production process is its scalability and resultant low cost of
production. SAF is used in such industries as architectural design,
military and automotive. Cymat markets its architectural SAF under
the AlusionTM brand and its automotive and military SAF
under the SmartMetalTM brand. For further information,
please visit our website at www.cymat.com.
Certain information set forth in this news release may
contain forward-looking statements that involve substantial known
and unknown risks and uncertainties. All statements other than
statements of historical fact are forward-looking statements,
including, without limitation, statements regarding the proposed
amendments to the Warrants, the Company's proposed use of proceeds
from the exercise of the Amended Warrants and the Incentive
Warrants, and objectives of or involving the Company. Such
forward-looking information reflects management's current beliefs
and is based on information currently available to management.
Often, but not always, forward-looking statements can be identified
by the use of words such as "plans", "expects", "is expected",
"budget", "scheduled", "estimates", "forecasts", "predicts",
"intends", "targets", "aims", "anticipates" or "believes" or
variations (including negative variations) of such words and
phrases or may be identified by statements to the effect that
certain actions "may", "could", "should", "would", "might" or
"will" be taken, occur or be achieved. A number of known and
unknown risks, uncertainties and other factors may cause the actual
results or performance to materially differ from any future results
or performance expressed or implied by the forward-looking
information. These forward-looking statements are subject to
numerous risks and uncertainties, certain of which are beyond the
control of the Company including, but not limited to, the failure
to obtain the Warrant Amendment Approval, failure to obtain
Exchange approval for the Warrant amendments and the Incentive
Program, impact of general economic conditions, industry conditions
and dependence upon regulatory approvals. Certain material
assumptions regarding such forward-looking statements may be
discussed in this news release and the Company's annual and
quarterly management's discussion and analysis filed at
www.sedar.com. Readers are cautioned that the assumptions used in
the preparation of such information, although considered reasonable
at the time of preparation, may prove to be imprecise and, as such,
undue reliance should not be placed on forward-looking statements.
The Company does not assume any obligation to update or revise its
forward-looking statements, whether as a result of new information,
future events, or otherwise, except as required by securities
laws.
No securities regulatory authority has either approved or
disapproved of the contents of this news release. The Shares have
not been, nor will they be, registered under the United States
Securities Act of 1933, as amended, or any state securities laws,
and may not be offered or sold in the
United States, or to or for the account or benefit of any
person in the United States,
absent registration or an applicable exemption from the
registration requirements. This press release shall not constitute
an offer to sell or the solicitation of an offer to buy any common
shares in the United States, or in
any other jurisdiction in which such offer, solicitation or sale
would be unlawful. We seek safe harbour.
Neither the Toronto Venture Exchange (TSXV) nor its Market
Regulator (as that term is defined in the policies of the TSXV)
accepts responsibility for the adequacy or accuracy of this news
release.
Not intended for distribution to United States Newswire
Services or for dissemination in the
United States. Any failure to comply with this restriction
may constitute a violation of United States Securities
laws.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cymat-reprices-warrants-and-announces-warrant-exercise-incentive-program-301764562.html
SOURCE Cymat Technologies Ltd.